| Mr Farid Faraj Zayed, MD | |
|
160 E Warwick Dr, Alma, MI 48801-1092 | |
| (989) 466-3621 | |
| (989) 466-3643 |
| Full Name | Mr Farid Faraj Zayed |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 37 Years |
| Location | 160 E Warwick Dr, Alma, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417913690 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Regional Medical Center - Appleton Inc | Appleton, WI | Hospital |
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Thedacare Medical Center-waupaca | Waupaca, WI | Hospital |
| Berlin Memorial Hospital | Berlin, WI | Hospital |
| Thedacare Medical Center - Shawano | Shawano, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thedacare Incorporated | 1759294887 | 493 |
News Archive
Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from the Tulip PETAL Study (703 Study), its fifth Phase 2 clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.
New research from the University of Washington and the University of Massachusetts - Amherst looks at how the most common cause of sneezing and sniffling in North America is likely to shift under climate change.
In the final week of debate before the Senate recess, the Finance Committee continues talks on bipartisan legislation, but both Republicans and Democrats are ramping up their health care rhetoric and considering more drastic options.
Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.
› Verified 2 days ago
| Entity Name | Thedacare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656959 PECOS PAC ID: 1759294887 Enrollment ID: O20031106000088 |
News Archive
Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from the Tulip PETAL Study (703 Study), its fifth Phase 2 clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.
New research from the University of Washington and the University of Massachusetts - Amherst looks at how the most common cause of sneezing and sniffling in North America is likely to shift under climate change.
In the final week of debate before the Senate recess, the Finance Committee continues talks on bipartisan legislation, but both Republicans and Democrats are ramping up their health care rhetoric and considering more drastic options.
Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Farid Faraj Zayed, MD 160 E Warwick Dr, Alma, MI 48801-1092 Ph: (989) 466-3621 | Mr Farid Faraj Zayed, MD 160 E Warwick Dr, Alma, MI 48801-1092 Ph: (989) 466-3621 |
News Archive
Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from the Tulip PETAL Study (703 Study), its fifth Phase 2 clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.
New research from the University of Washington and the University of Massachusetts - Amherst looks at how the most common cause of sneezing and sniffling in North America is likely to shift under climate change.
In the final week of debate before the Senate recess, the Finance Committee continues talks on bipartisan legislation, but both Republicans and Democrats are ramping up their health care rhetoric and considering more drastic options.
Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.
› Verified 2 days ago
Dr. Mark Kevin Jacob, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 300 E Warwick Dr, Alma, MI 48801 Phone: 989-774-1101 | |
Dr. Sudeep Mohan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 315 E Warwick Dr, Suite E, Alma, MI 48801 Phone: 989-466-2877 Fax: 989-466-5116 | |
Dr. Jeanine Ernest, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 E Warwick Dr, Alma, MI 48801 Phone: 989-463-5876 Fax: 989-466-5956 | |
Abraham Krepostman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 315 E Warwick Dr, Suite E, Alma, MI 48801 Phone: 989-463-0672 Fax: 989-466-5116 | |
Radwan Alkiek, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 160 E Warwick Dr, Alma, MI 48801 Phone: 855-466-3621 Fax: 989-466-3643 | |
Tamara Kurbanova, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 300 E Warwick Dr, Alma, MI 48801 Phone: 989-839-1644 |